Cargando…
Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
Facing the emergence of difficult-to-treat bacterial infections, the perspective of using bacteriophages has re-gained interest in many countries. In terms of pharmaceutical classification in EU and United States, phages are considered as anti-infectious medicinal products and biological products, g...
Autores principales: | Bretaudeau, Laurent, Tremblais, Karine, Aubrit, Françoise, Meichenin, Marc, Arnaud, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287015/ https://www.ncbi.nlm.nih.gov/pubmed/32582101 http://dx.doi.org/10.3389/fmicb.2020.01161 |
Ejemplares similares
-
Moving analytical ultracentrifugation software to a good manufacturing practices (GMP) environment
por: Savelyev, Alexey, et al.
Publicado: (2020) -
Exosomes in clinical trial and their production in compliance with good manufacturing practice
por: Chen, Yu-Shuan, et al.
Publicado: (2019) -
Validation of analytical methods in compliance with good manufacturing practice: a practical approach
por: Rustichelli, Deborah, et al.
Publicado: (2013) -
Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
por: Souto, Eliana B., et al.
Publicado: (2020) -
Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance
por: Nath, Suman C., et al.
Publicado: (2020)